Frequency and Predictors of the Lupus Low Disease Activity State in a Multi-National and Multi-Ethnic Cohort

Vera Golder,Rangi Kandane-Rathnayake,Alberta Yik-Bun Hoi,Molla Huq,Worawit Louthrenoo,Yuan An,Zhan Guo Li,Shue Fen Luo,Sargunan Sockalingam,Chak Sing Lau,Alfred Lok Lee,Mo Yin Mok,Aisha Lateef,Kate Franklyn,Susan Morton,Sandra Teresa V. Navarra,Leonid Zamora,Yeong-Jian Wu,Laniyati Hamijoyo,Madelynn Chan,Sean O’Neill,Fiona Goldblatt,Eric Francis Morand,Mandana Nikpour,for the Asia-Pacific Lupus Collaboration

DOI: https://doi.org/10.1186/s13075-016-1163-2

2016-01-01

Arthritis Research & Therapy

Abstract:Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable burden from disease activity and damage. A novel clinical treatment target in the form of the lupus low disease activity state (LLDAS) has been recently reported, with retrospective validation showing that time spent in LLDAS translates to reduced damage accrual. The objectives of this study were to describe the frequency and identify the predictors of attaining LLDAS in a large multinational cohort of patients with SLE.